Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography

Journal of the National Cancer Institute

Volumn 90, Issue 11, 1998, Pages 846-849

  Tolmos, Jorge ^a   Cutrone, John A ^a   Wang, Benjamin ^b   Vargas, Hernan I ^a   Stuntz, Michael ^a   Mishkin, Fred S ^a   Diggles, Linda E ^a   Venegas, Rose J ^a   Klein, Stanley R ^a   Khalkhali, Iraj ^a,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b ST MARY MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; BREAST TUMOR; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREDICTION; SCREENING TEST;

EID: 0038388427     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.11.846     Document Type: Article

References (31)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46: 5-27.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47: 5-27.
3. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88: 1571-9.
4. Perdue PW, Galbo C, Ghosh BC. Stratification of palpable and nonpalpable breast cancer by method of detection and age. Ann Surg Oncol 1995;2:512-5.
5. Bauer TL, Pandelidis SM, Rhoads JE, Owens RS. Mammographically detected carcinoma of the breast. Surg Gynecol Obstet 1991;173: 482-6.
6. Wilhelm MC, Edge SB, Cole DD, deParedes E, Frierson HF Jr. Nonpalpable invasive breast cancer. Ann Surg 1991;213:600-3.
7. Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, et al. Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65. Int J Cancer 1997;70: 164-8.
8. Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, Mravunac M, et al. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. Int J Cancer 1996;66:727-31.
9. Baker LH. Breast cancer detection demonstration project: five-year summary report. CA Cancer J Clin 1982;32:194-225.
10. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
11. Chen HH, Tabar L, Fagerberg G, Duffy SW. Effect of breast cancer screening after age 65. J Med Screen 1995;2:10-4.
12. Larsson LG, Nystrom L, Wall S, Rutqvist L, Andersson I, Bjurstam N, et al. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality. J Med Screen 1996;3: 129-32.
13. Frisell J, Eklund G, Hellstrom L, Glas U, Somell A. The Stockholm breast cancer screening trial-5-year results and stage at discovery. Breast Cancer Res Treat 1989;13: 79-87.
14. Andersson I, Fagerberg G, Lundgren B, Tabar L. Breast cancer screening in Sweden. The single modality approach. Radiologe 1980;20: 608-11.
15. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276: 33-8.
16. Jackson VP, Hendrick RE, Feig SA, Kopans DB. Imaging of the radiographically dense breast. Radiology 1993;188:297-301.
17. Kopans DB, Moore RH, McCarthy KA, Hall DA, Hulka CA, Whitman GJ, et al. Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years. Radiology 1996;200: 357-60.
18. Adler DD, Wahl RL. New methods for imaging the breast: techniques, findings, and potential. AJR Am J Roentgenol 1995;164:19-30.
19. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784-9.
20. Burak Z, Argon M, Memis A, Erdem S, Balkan Z, Duman Y, et al. Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994;15: 604-12.
21. American College of Radiology (ACR). Breast imaging reporting and data system (BIRADS). 2nd edition ed. Reston, VA: American College of Radiology, 1995.
22. Bland K, Copeland E. Breast. In: Schwartz S, Shires T, Spencer F, editors. Principles of surgery. 6th ed. New York: McGraw-Hill, 1994: 545.
23. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: Wiley, 1981.
24. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988;297:943-8.
25. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21:432-6.
26. Clifford EJ, Lugo-Zamudio C. Scintimammography in the diagnosis of breast cancer. Am J Surg 1996;172:483-6.
27. Palmedo H, Grunwald F, Bender H, Schomburg A, Mallmann P, Krebs D, et al. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 1996;23:940-6.
28. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-65.
29. Maffioli L, Agresti R, Chiti A, Crippa F, Gasparini M, Greco M, et al. Prone scintimammography in patients with non-palpable breast lesions. Anticancer Res 1996;16:1269-73.
30. Cutrone JA, Yospur LS, Khalkhali I, Tolmos J, Devito A, Vargas PM, et al. Immunohistologic assessment of Tc-99m sestamibi uptake in benign and malignant breast lesions. J Nucl Med 1998;39:449-53.
31. Beer GM, Kompatscher P, Hergan K. Diagnosis of breast tumors after breast reduction. Aesthetic Plast Surg 1996;20:391-7.